Commonwealth Consolidated Regulations Commonwealth Consolidated Regulations(1) For the purposes of paragraph 12N(1)(d) of the Act, the following matters are prescribed in relation to a manufacture licence:
(a) a security breach, a suspected security breach, an unauthorised access or a suspected unauthorised access, in relation to the location, premises or facilities covered by the licence;
(b) a theft, or a suspected theft, of narcotic drugs or starting materials in relation to such drugs from the location, premises or facilities covered by the licence;
(c) a loss, or a suspected loss, of narcotic drugs or starting materials in relation to such drugs at the location, premises or facilities covered by the licence;
(d) a discrepancy, or a suspected discrepancy, in the quantity of narcotic drugs or starting materials in relation to such drugs in the possession or under the control of the licence holder;
(e) a loss, or a suspected loss, of narcotic drugs or starting materials in relation to such drugs in the possession or under the control of the licence holder, other than at the location, premises or facilities covered by the licence, including during transportation of the narcotic drugs or starting materials;
(f) a serious incident involving a narcotic drug or starting material in relation to such a drug in the possession or under the control of the licence holder during transportation of the narcotic drugs or starting materials;
(g) an adverse finding or a recommendation, relating to security matters, made in a security audit report or other report relating to the location, premises or facilities covered by the licence;
(h) a change made, or proposed to be made, by the licence holder in relation to premises, security arrangements, conduct of activities, record - keeping, staff or contractors, or other arrangements relating to the licence, in response to any of the following:
(i) a direction of the Secretary under section 14P of the Act;
(ii) a new condition imposed on the manufacture licence under the Act;
(iii) a variation of the licence or of a manufacture permit that relates to the licence;
(iv) a finding or a recommendation notified to the licence holder and arising from the monitoring, inspection or investigation of the activities covered by the licence;
(i) the licence holder commences to manufacture a narcotic drug under the licence;
(j) the licence holder ceases to undertake, or proposes to cease undertaking, the manufacture of a narcotic drug or any other activities authorised by the licence;
(k) if the licence holder is a body corporate--a transaction that results in, or a proposed transaction that will result in, a change to the type, name or number of shares in the body corporate that are held by a person;
(l) if the licence holder is a body corporate--a change, or a proposed change, in any of the directors or officers of the body corporate;
(m) the licence holder has been notified that a Commonwealth, State or Territory agency has commenced to inquire into, or investigate, any actions, conduct or activities relating to the location, premises or facilities covered by the licence.
(2) For the purposes of paragraph 12N(2)(a) of the Act, the period for a matter covered by paragraph (1)(a), (b), (c), (d), (e) or (f) of this section is 72 hours starting when the matter comes to the attention of the licence holder.